Relative effectiveness and safety of pharmacotherapeutic agents for patent ductus arteriosus (PDA) in preterm infants: a protocol for a multicentre comparative effectiveness study (CANRxPDA)

INTRODUCTION: Patent ductus arteriosus (PDA) is the most common cardiovascular problem that develops in preterm infants and evidence regarding the best treatment approach is lacking. Currently available medical options to treat a PDA include indomethacin, ibuprofen or acetaminophen. Wide variation e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMJ Open
Asıl Yazarlar: Mitra, Souvik, Jain, Amish, Ting, Joseph Y., Ben Fadel, Nadya, Drolet, Christine, Abou Mehrem, Ayman, Soraisham, Amuchou, Jasani, Bonny, Louis, Deepak, Lapointe, Anie, Dorling, Jon, Khurshid, Faiza, Hyderi, Abbas, Kumaran, Kumar, Bodani, Jaya, Weisz, Dany, Alvaro, Ruben, Adie, Mohammed, Stavel, Miroslav, Morin, Alyssa, Bhattacharya, Soume, Kanungo, Jaideep, Canning, Rody, Ye, Xiang Y, Hatfield, Tara, Gardner, Courtney E, Shah, Prakesh
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Paediatrics
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8103361/
https://ncbi.nlm.nih.gov/pubmed/33952559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2021-050682
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller